METASTATIC LIVER CANCER
Clinical trials for METASTATIC LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LIVER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental T-Cell therapy for liver cancer shows early promise but trial halted
Disease control TerminatedThis early-stage trial tested a new treatment called ET140203 T cells for adults with advanced liver cancer that had not responded to other therapies. The treatment uses a patient's own immune cells, modified to target cancer cells. The study was stopped early after enrolling onl…
Matched conditions: METASTATIC LIVER CANCER
Phase: PHASE1 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
Liver cancer software tool tested, but study ends early
Knowledge-focused TerminatedThis pilot study tested a software called BioTraceIO 360, designed to help doctors plan and monitor liver tumor ablation (a procedure that destroys tumors with heat). The study aimed to enroll 30 people with liver cancer, but was terminated early with only 4 participants. The goa…
Matched conditions: METASTATIC LIVER CANCER
Phase: NA • Sponsor: Techsomed Medical Technologies LTD • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC